Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial.
Health-related quality of life
Oxidative stress
Spirulina
Ulcerative colitis
Journal
BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232
Informations de publication
Date de publication:
29 Feb 2024
29 Feb 2024
Historique:
received:
08
02
2023
accepted:
13
02
2024
medline:
1
3
2024
pubmed:
1
3
2024
entrez:
29
2
2024
Statut:
epublish
Résumé
We conducted a randomized placebo-controlled trial to assess the efficacy of Spirulina (SP) supplementation on disease activity, health-related quality of life, antioxidant status, and serum pentraxin 3 (PTX-3) levels in patients with ulcerative colitis (UC). Eighty patients with UC were randomly assigned to consume either 1 g/day (two 500 mg capsules/day) of SP (n = 40) or control (n = 40) for 8 weeks. Dietary intakes, physical activity, disease activity, health-related quality of life, antioxidant status, erythrocyte sedimentation rate (ESR), and serum PTX-3 levels were assessed and compared between groups at baseline and post-intervention. Seventy-three patients (91.3%) completed the trial. We observed increases in serum total antioxidant capacity levels in the SP supplementation group compared to the control group after 8 weeks of intervention (p ≤ 0.001). A within-group comparison indicated a trend towards a higher health-related quality of life score after 8 weeks of taking two different supplements, SP (p < 0.001) and PL (p = 0.012), respectively. However, there were no significant changes in participant's disease activity score in response to SP administration (p > 0.05). Similarly, changes in ESR and PTX-3 levels were comparable between groups post-intervention (p > 0.05). SP improved antioxidant capacity status and health-related quality of life in patients with UC. Our findings suggest that SP supplementation may be effective as an adjuvant treatment for managing patients with UC. Larger trials with longer interventions periods are required to confirm our findings.
Identifiants
pubmed: 38424572
doi: 10.1186/s12906-024-04400-w
pii: 10.1186/s12906-024-04400-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109Informations de copyright
© 2024. The Author(s).
Références
Pithadia AB, Jain S. Treatment of inflammatory bowel disease (IBD). Pharmacol Rep. 2011;63(3):629–42.
pubmed: 21857074
doi: 10.1016/S1734-1140(11)70575-8
El-Abhar HS, Hammad LN, Gawad HSA. Modulating effect of ginger extract on rats with ulcerative colitis. J Ethnopharmacol. 2008;118(3):367–72.
pubmed: 18571884
doi: 10.1016/j.jep.2008.04.026
Gophna U, et al. Differences between tissue-associated intestinal microfloras of patients with Crohn’s disease and ulcerative colitis. J Clin Microbiol. 2006;44(11):4136–41.
pubmed: 16988016
pmcid: 1698347
doi: 10.1128/JCM.01004-06
Thompson AI, Lees CW. Genetics of ulcerative colitis. Inflamm Bowel Dis. 2011;17(3):831–48.
pubmed: 21319274
doi: 10.1002/ibd.21375
Hanauer SB. Update on the etiology, pathogenesis and diagnosis of ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2004;1(1):26–31.
pubmed: 16265041
doi: 10.1038/ncpgasthep0031
Yangyang RY, Rodriguez JR. Clinical presentation of Crohn’s, ulcerative colitis, and indeterminate colitis: symptoms, extraintestinal manifestations, and disease phenotypes. In: Seminars in pediatric surgery. Elsevier; 2017.
Ishihara S, et al. Irritable bowel syndrome-like symptoms in ulcerative colitis patients in clinical remission: association with residual colonic inflammation. Digestion. 2019;99(1):46–51.
pubmed: 30554229
doi: 10.1159/000494412
Chaubal A, et al. Anemia in patients with ulcerative colitis in remission: a study from western India. Indian J Gastroenterol. 2017;36(5):361–5.
pubmed: 28993978
doi: 10.1007/s12664-017-0791-z
Tibble JA, Bjarnason I. Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol. 2001;7(4):460–5.
pubmed: 11819811
pmcid: 4688655
doi: 10.3748/wjg.v7.i4.460
Cioffi M, et al. Laboratory markers in ulcerative colitis: current insights and future advances. World J Gastrointest Pathophysiol. 2015;6(1):13.
pubmed: 25685607
pmcid: 4325297
doi: 10.4291/wjgp.v6.i1.13
Wu Q, et al. Pentraxin 3: a promising therapeutic target for autoimmune diseases. Autoimmun Rev. 2020;19(12):102584.
pubmed: 32534154
doi: 10.1016/j.autrev.2020.102584
Kalyon S, Gökden Y, Oyman F. A new biological marker in inflammatory bowel disease: Pentraxin 3. J Surg Med. 2020;4(10):875–8.
doi: 10.28982/josam.791156
Ishida N, et al. C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis. Sci Rep. 2021;11(1):1–8.
doi: 10.1038/s41598-021-90558-z
Savchenko AS, et al. Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis. Pathol Int. 2011;61(5):290–7.
pubmed: 21501295
doi: 10.1111/j.1440-1827.2011.02651.x
Kato S, et al. Increased expression of long pentraxin PTX3 in inflammatory bowel diseases. Dig Dis Sci. 2008;53(7):1910–6.
pubmed: 17990107
doi: 10.1007/s10620-007-0075-z
Danese S, Fiorino G, Peyrin-Biroulet L. Positioning therapies in ulcerative colitis. Clin Gastroenterol Hepatol. 2020;18(6):1280-1290.e1.
pubmed: 31982609
doi: 10.1016/j.cgh.2020.01.017
Lamb CA, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1–106.
pubmed: 31562236
doi: 10.1136/gutjnl-2019-318484
Naganuma M, et al. Recent trends and future directions for the medical treatment of ulcerative colitis. Clin J Gastroenterol. 2016;9(6):329–36.
pubmed: 27699641
doi: 10.1007/s12328-016-0686-z
Nikkhah-Bodaghi M, et al. The effects of Nigella sativa on quality of life, disease activity index, and some of inflammatory and oxidative stress factors in patients with ulcerative colitis. Phytother Res. 2019;33(4):1027–32.
pubmed: 30666747
doi: 10.1002/ptr.6296
Rastegarpanah M, et al. A randomized, double blinded, placebo-controlled clinical trial of silymarin in ulcerative colitis. Chin J Integr Med. 2015;21(12):902–6.
pubmed: 22528757
doi: 10.1007/s11655-012-1026-x
Nikkhah-Bodaghi M, et al. Zingiber officinale and oxidative stress in patients with ulcerative colitis: a randomized, placebo-controlled, clinical trial. Complement Ther Med. 2019;43:1–6.
pubmed: 30935515
doi: 10.1016/j.ctim.2018.12.021
Sadeghi N, et al. The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis. Phytother Res. 2020;34(5):1123–33.
pubmed: 31802559
doi: 10.1002/ptr.6581
Samsamikor M, et al. Resveratrol supplementation and oxidative/anti-oxidative status in patients with ulcerative colitis: a randomized, double-blind, placebo-controlled pilot study. Arch Med Res. 2016;47(4):304–9.
pubmed: 27664491
doi: 10.1016/j.arcmed.2016.07.003
Amiri M, et al. Efficacy and safety of a standardized extract from Achillea wilhelmsii C. Koch in patients with ulcerative colitis: a randomized double blind placebo-controlled clinical trial. Complement Ther Med. 2019;45:262–8.
pubmed: 31331572
doi: 10.1016/j.ctim.2019.05.001
Kulshreshtha A, et al. Spirulina in health care management. Curr Pharm Biotechnol. 2008;9(5):400–5.
pubmed: 18855693
doi: 10.2174/138920108785915111
Yousefi R, Saidpour A, Mottaghi A. The effects of Spirulina supplementation on metabolic syndrome components, its liver manifestation and related inflammatory markers: a systematic review. Complement Ther Med. 2018;42.
Wu Q, et al. The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview. Arch Toxicol. 2016;90:1817–40.
pubmed: 27259333
doi: 10.1007/s00204-016-1744-5
Mazokopakis EE, et al. The hypolipidaemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population: a prospective study. J Sci Food Agric. 2014;94(3):432–7.
pubmed: 23754631
doi: 10.1002/jsfa.6261
Suliburska J, et al. Effect of Spirulina maxima supplementation on calcium, magnesium, iron, and zinc status in obese patients with treated hypertension. Biol Trace Elem Res. 2016;173(1):1–6.
pubmed: 26779620
pmcid: 4975759
doi: 10.1007/s12011-016-0623-5
Neyrinck AM, et al. Spirulina protects against hepatic inflammation in aging: an effect related to the modulation of the gut microbiota? Nutrients. 2017;9(6):633.
pubmed: 28632181
pmcid: 5490612
doi: 10.3390/nu9060633
Bobescu E, et al. Are there any beneficial effects of Spirulina supplementation for metabolic syndrome components in postmenopausal women? Mar Drugs. 2020;18(12):651.
pubmed: 33348926
pmcid: 7767256
doi: 10.3390/md18120651
Guazelli CF, et al. Antioxidant and anti-inflammatory effects of hesperidin methyl chalcone in experimental ulcerative colitis. Chem Biol Interact. 2021;333:109315.
pubmed: 33171134
doi: 10.1016/j.cbi.2020.109315
Zuo K, et al. Purification and antioxidant and anti-inflammatory activity of extracellular polysaccharopeptide from sanghuang mushroom, Sanghuangporus lonicericola. J Sci Food Agric. 2021;101(3):1009–20.
pubmed: 32767366
doi: 10.1002/jsfa.10709
Tzachor A, et al. Photosynthetically controlled Spirulina, but not solar Spirulina, inhibits TNF-α secretion: potential implications for COVID-19-related cytokine storm therapy. Mar Biotechnol. 2021;23(1):149–55.
doi: 10.1007/s10126-021-10020-z
Szulinska M, et al. Spirulina maxima improves insulin sensitivity, lipid profile, and total antioxidant status in obese patients with well-treated hypertension: a randomized double-blind placebo-controlled study. Eur Rev Med Pharmacol Sci. 2017;21(10):2473–81.
pubmed: 28617537
Kordi MR, Attarzade Hosseini SR, Davaloo T. Aerobic exercises and supplement Spirulina reduce inflammation in diabetic men. J Jahrom Univer Med Sci. 2018;16(4):10–8.
Morsy MA, et al. Protective effect of Spirulina platensis extract against dextran-sulfate-sodium-induced ulcerative colitis in rats. Nutrients. 2019;11(10):2309.
pubmed: 31569451
pmcid: 6836255
doi: 10.3390/nu11102309
El-Boghdady NA, Kamel MA, El-Shamy RM. Omeprazole and Spirulina platensis ameliorate Steatohepatitis in experimental nonalcoholic fatty liver disease. Metab Syndr Relat Disord. 2020;18(9):426–34.
pubmed: 32795119
doi: 10.1089/met.2019.0129
Windari HAS, et al. Antioxidant activity of Spirulina platensis and sea cucumber Stichopus hermanii in Streptozotocin-induced diabetic rats. Trop Life Sci Res. 2019;30(2).
Gómez-Téllez A, et al. Effects of a low-dose Spirulina/turmeric supplement on Cardiometabolic and antioxidant serum markers of patients with abdominal obesity. Front Nutr. 2020;7.
Nasirian F, et al. Effects of Spirulina platensis microalgae on antioxidant and anti-inflammatory factors in diabetic rats. Diabet Metab Syndr Obes: Targets Ther. 2018;11:375.
doi: 10.2147/DMSO.S172104
Martínez-Sámano J, et al. Spirulina maxima decreases endothelial damage and oxidative stress indicators in patients with systemic arterial hypertension: results from exploratory controlled clinical trial. Mar Drugs. 2018;16(12):496.
pubmed: 30544795
pmcid: 6315658
doi: 10.3390/md16120496
Jowett S, et al. Defining relapse of ulcerative colitis using a symptom-based activity index. Scand J Gastroenterol. 2003;38(2):164–71.
pubmed: 12678333
doi: 10.1080/00365520310000654
Zeinalian R, et al. The effects of Spirulina platensis on anthropometric indices, appetite, lipid profile and serum vascular endothelial growth factor (VEGF) in obese individuals: a randomized double blinded placebo controlled trial. BMC Complement Altern Med. 2017;17(1):1–8.
doi: 10.1186/s12906-017-1670-y
Mazokopakis EE, et al. The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study. Ann Gastroenterol: Q Publ Hellenic Soc Gastroenterol. 2014;27(4):387.
Rezaei N, et al. The protective effects of honey and spirulina platensis on acetic acid-induced ulcerative colitis in rats. Iran Red Crescent Med J. 2018;20(4):8.
doi: 10.5812/ircmj.62517
Dai Y-C, et al. Effects of Jianpi Qingchang decoction on the quality of life of patients with ulcerative colitis: a randomized controlled trial. Medicine. 2017;96(16):e6651.
pubmed: 28422869
pmcid: 5406085
doi: 10.1097/MD.0000000000006651
Naganuma M, et al. Efficacy of indigo Naturalis in a multicenter randomized controlled trial of patients with ulcerative colitis. Gastroenterology. 2018;154(4):935–47.
pubmed: 29174928
doi: 10.1053/j.gastro.2017.11.024
Committee, I.R., Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-short and long forms. http://www.ipaq.ki.se/scoring.pdf , 2005.
Walmsley R, et al. A simple clinical colitis activity index. Gut. 1998;43(1):29–32.
pubmed: 9771402
pmcid: 1727189
doi: 10.1136/gut.43.1.29
Jowett SL, et al. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol. 2001;96(10):2921–8.
pubmed: 11693327
doi: 10.1111/j.1572-0241.2001.04682.x
Bijari B, Soltani B. Validation of the Persian version of inflammatory bowel disease questionnaire in patients who referred to clinics and hospitals of Birjand university of medical sciences, Iran. Ann Colorectal Res. 2017;5(1-2).
Faul F, et al. G* power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91.
pubmed: 17695343
doi: 10.3758/BF03193146
Langmead L, et al. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther. 2004;19(7):739–47.
pubmed: 15043514
doi: 10.1111/j.1365-2036.2004.01902.x
Kamali M, et al. Efficacy of the Punica granatum peels aqueous extract for symptom management in ulcerative colitis patients. A randomized, placebo-controlled, clinical trial. Complement Ther Clin Pract. 2015;21(3):141–6.
pubmed: 26256131
doi: 10.1016/j.ctcp.2015.03.001
Park WS, et al. Two classes of pigments, carotenoids and c-phycocyanin, in spirulina powder and their antioxidant activities. Molecules. 2018;23(8):2065.
pubmed: 30126131
pmcid: 6222893
doi: 10.3390/molecules23082065
Coskun ZK, et al. The study of biochemical and histopathological effects of spirulina in rats with TNBS-induced colitis. Bratisl Lek Listy. 2011;112(5):235–43.
pubmed: 21682075
Abdel-Daim MM, et al. Anti-inflammatory and immunomodulatory effects of Spirulina platensis in comparison to Dunaliella salina in acetic acid-induced rat experimental colitis. Immunopharmacol Immunotoxicol. 2015;37(2):126–39.
pubmed: 25567297
doi: 10.3109/08923973.2014.998368
Ismail M, et al. Effect of spirulina intervention on oxidative stress, antioxidant status, and lipid profile in chronic obstructive pulmonary disease patients. Biomed Res Int. 2015;2015.
Yousefi R, Saidpour A, Mottaghi A. The effects of Spirulina supplementation on metabolic syndrome components, its liver manifestation and related inflammatory markers: a systematic review. Complement Ther Med. 2019;42:137–44.
pubmed: 30670232
doi: 10.1016/j.ctim.2018.11.013
Grover P, et al. C-Phycocyanin-a novel protein from Spirulina platensis- in vivo toxicity, antioxidant and immunomodulatory studies. Saudi J Biol Sci. 2021;28(3):1853–9.
pubmed: 33732072
doi: 10.1016/j.sjbs.2020.12.037
Schafer FQ, et al. Comparing β-carotene, vitamin E and nitric oxide as membrane antioxidants. Biol Chem. 2002;383(3–4):671–81.
pubmed: 12033456
Rasmussen B, et al. Predictors of health-related quality of life in patients with moderate to severely active ulcerative colitis receiving biological therapy. Scand J Gastroenterol. 2020;55(6):656–63.
pubmed: 32442051
doi: 10.1080/00365521.2020.1768282
van der Waal MB, et al. Probiotics for improving quality of life in ulcerative colitis: exploring the patient perspective. PharmaNutrition. 2019;7:100139.
doi: 10.1016/j.phanu.2018.100139
Amiriani T, et al. Effect of Lactocare® synbiotic on disease severity in ulcerative colitis: a randomized placebo-controlled double-blind clinical trial. Middle East J Dig Dis. 2020;12(1):27.
pubmed: 32082518
pmcid: 7023645
doi: 10.15171/mejdd.2020.160
Shirazi KM, et al. Effect of N-acetylcysteine on remission maintenance in patients with ulcerative colitis: a randomized, double-blind controlled clinical trial. Clin Res Hepatol Gastroenterol. 2020;45.
Dhillon P, Singh K. Therapeutic applications of probiotics in ulcerative colitis: an updated review. PharmaNutrition. 2020;13:100194.
doi: 10.1016/j.phanu.2020.100194
Dang X, et al. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL# 3 for active ulcerative colitis: a systematic review and meta-analysis. PLoS One. 2020;15(3):e0228846.
pubmed: 32182248
pmcid: 7077802
doi: 10.1371/journal.pone.0228846
Astó E, et al. The efficacy of probiotics, prebiotic inulin-type fructans, and synbiotics in human ulcerative colitis: a systematic review and meta-analysis. Nutrients. 2019;11(2):293.
pubmed: 30704039
pmcid: 6412539
doi: 10.3390/nu11020293
Hu J, et al. Dose effects of orally administered Spirulina suspension on colonic microbiota in healthy mice. Front Cell Infect Microbiol. 2019;9:243.
pubmed: 31334136
pmcid: 6624478
doi: 10.3389/fcimb.2019.00243
Finamore A, et al. Antioxidant, immunomodulating, and microbial-modulating activities of the sustainable and ecofriendly spirulina. Oxidative Med Cell Longev. 2017;2017.
Parada JL, et al. Lactic acid bacteria growth promoters from Spirulina platensis. Int J Food Microbiol. 1998;45(3):225–8.
pubmed: 9927000
doi: 10.1016/S0168-1605(98)00151-2
Beheshtipour H, et al. Supplementation of Spirulina platensis and Chlorella vulgaris algae into probiotic fermented milks. Compr Rev Food Sci Food Saf. 2013;12(2):144–54.
doi: 10.1111/1541-4337.12004
Kaka R, et al. The effect of nonlinear resistance training with supplementation of Spirulina on serum leptin and ghrelin in obese women. J Appl Health Stud Sport Physiol. 2019;6(1):69–77.
Karmiris K, Koutroubakis IE, Kouroumalis EA. Leptin, adiponectin, resistin, and ghrelin–implications for inflammatory bowel disease. Mol Nutr Food Res. 2008;52(8):855–66.
pubmed: 18383234
doi: 10.1002/mnfr.200700050
Ghomraoui FA, et al. Plasma ghrelin and leptin in patients with inflammatory bowel disease and its association with nutritional status. Saudi J Gastroenterol: Off J Saudi Gastroenterol Assoc. 2017;23(3):199.
doi: 10.4103/sjg.SJG_575_16
Jung JY, et al. Circulating ghrelin levels and obestatin/ghrelin ratio as a marker of activity in ulcerative colitis. Intest Res. 2015;13(1):68–73.
pubmed: 25691845
pmcid: 4316225
doi: 10.5217/ir.2015.13.1.68
Biesiada G, et al. Expression and release of leptin and proinflammatory cytokines in patients with ulcerative colitis and infectious diarrhea. J Physiol Pharmacol. 2012;63(5):471–81.
pubmed: 23211301
Fujimoto M, et al. Spirulina improves non-alcoholic steatohepatitis, visceral fat macrophage aggregation, and serum leptin in a mouse model of metabolic syndrome. Dig Liver Dis. 2012;44(9):767–74.
pubmed: 22444524
doi: 10.1016/j.dld.2012.02.002
Heo M-G, Choung S-Y. Anti-obesity effects of Spirulina maxima in high fat diet induced obese rats via the activation of AMPK pathway and SIRT1. Food Funct. 2018;9(9):4906–15.
pubmed: 30178808
doi: 10.1039/C8FO00986D
Akbarpour M, Samari Z. The effect of aerobic training and Spirulina supplementation on Resistin and C-reactive protein in women with type 2 diabetes with overweight. KAUMS J (FEYZ). 2020;24(5):576–84.
Mahmoud YI, et al. Spirulina inhibits hepatocellular carcinoma through activating p53 and apoptosis and suppressing oxidative stress and angiogenesis. Life Sci. 2021;265:118827.
pubmed: 33253720
doi: 10.1016/j.lfs.2020.118827
Elbialy ZI, et al. Healing potential of Spirulina platensis for skin wounds by modulating bFGF, VEGF, TGF-ß1 and α-SMA genes expression targeting angiogenesis and scar tissue formation in the rat model. Biomed Pharmacother. 2021;137:111349.
pubmed: 33567349
doi: 10.1016/j.biopha.2021.111349
Mateescu RB, et al. Vascular endothelial growth factor-key mediator of angiogenesis and promising therapeutical target in ulcerative colitis. Romanian J Morphol Embryol. 2017;58(4):1339–45.
Aksoy EK, et al. Vascular endothelial growth factor, endostatin levels and clinical features among patients with ulcerative colitis and irritable bowel syndrome and among healthy controls: a cross-sectional analytical study. Sao Paulo Med J. 2018;136(6):543–50.
pubmed: 30892485
doi: 10.1590/1516-3180.2018.0274161118
Sandor Z, et al. Altered angiogenic balance in ulcerative colitis: a key to impaired healing? Biochem Biophys Res Commun. 2006;350(1):147–50.
pubmed: 17011522
doi: 10.1016/j.bbrc.2006.09.021
Aldina R, Haryati SW. Effect of Spirulina platensis extract on vascular endothelial growth factor (VEGF) expression in corneal inflammation in rat (Rattus novergicus) strain wistar. EurAsian J BioSci. 2019;13(2):823–9.
Zeinalian R, et al. The effects of Spirulina platensis on anthropometric indices, appetite, lipid profile and serum vascular endothelial growth factor (VEGF) in obese individuals: a randomized double blinded placebo controlled trial. BMC Complement Altern Med. 2017;17(1):225.
pubmed: 28431534
pmcid: 5399840
doi: 10.1186/s12906-017-1670-y
Mehdinezhad N, et al. Effect of spirulina and chlorella alone and combined on the healing process of diabetic wounds: an experimental model of diabetic rats. J Diab Metab Disord. 2021;20.
Ercan G, Yigitturk G, Erbas O. Therapeutic effect of adenosine on experimentally induced acute ulcerative colitis model in rats. Acta Cir Bras. 2019;34(12).
Rubin DT, et al. Budesonide multimatrix is efficacious for mesalamine-refractory, mild to moderate ulcerative colitis: a randomised, placebo-controlled trial. J Crohn’s Colitis. 2017;11(7):785–91.
doi: 10.1093/ecco-jcc/jjx032